However, there are different breast cancer subtypes, including HER2-positive breast cancer, luminal A and B breast cancer, and TNBC, and comprehensive studies on the ceRNA networks in each breast cancer subtype are limited, particularly regarding the identification of their specific molecular mechanisms. This evidence concerns the gene ERBB2 and breast carcinoma.